Back to Journals » OncoTargets and Therapy » Volume 16

Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context

Total article views   HTML views PDF downloads Totals
3,966 Dovepress* 3,192+ 112 3,304
PubMed Central* 774 191 965
Totals 3,966 303 4,269
*Since 20 July 2023
Total mentioned Facebook Delicious Reddit Twitter Others
20 0 0 0 10 10

View citations on PubMed Central and Google Scholar